Want to see IN:SUNPHARMA full AI Analyst Report?

Sun Pharmaceutical Industries Limited (SUNPHARMA) Financial Statements

19 Followers

Sun Pharmaceutical Industries Limited Financial Overview

Sun Pharmaceutical Industries Limited's market cap is currently ₹4.57T. The company's EPS TTM is ₹43.6; its P/E ratio is 39.11; and it has a dividend yield of 0.91%. Sun Pharmaceutical Industries Limited is scheduled to report earnings on May 22, 2026, and the estimated EPS forecast is ₹12.01. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 584.62B	₹ 525.78B	₹ 484.97B	₹ 438.86B	₹ 386.54B
Gross Profit	₹ 325.62B	₹ 410.20B	₹ 370.55B	₹ 325.67B	₹ 277.78B
Operating Income	₹ 135.53B	₹ 278.15B	₹ 244.24B	₹ 219.04B	₹ 182.91B
EBITDA	₹ 183.40B	₹ 149.68B	₹ 128.76B	₹ 116.51B	₹ 101.54B
Net Income	₹ 114.79B	₹ 109.29B	₹ 95.76B	₹ 84.74B	₹ 32.73B
Balance Sheet
Cash & Short-Term Investments	₹ 325.37B	₹ 249.88B	₹ 190.90B	₹ 159.07B	₹ 126.55B
Total Assets	₹ 1.09T	₹ 921.01B	₹ 854.63B	₹ 807.44B	₹ 698.00B
Total Debt	₹ 45.96B	₹ 23.62B	₹ 32.74B	₹ 68.90B	₹ 12.90B
Net Debt	₹ -70.07B	₹ -89.69B	₹ -60.12B	₹ 22.66B	₹ -32.18B
Total Liabilities	₹ 249.05B	₹ 196.15B	₹ 183.57B	₹ 214.28B	₹ 187.34B
Stockholders' Equity	₹ 835.70B	₹ 722.18B	₹ 636.67B	₹ 559.95B	₹ 480.11B
Cash Flow
Free Cash Flow	₹ 92.42B	₹ 119.44B	₹ 99.33B	₹ 28.74B	₹ 74.89B
Operating Cash Flow	₹ 128.52B	₹ 140.72B	₹ 121.35B	₹ 49.59B	₹ 89.85B
Investing Cash Flow	₹ -121.08B	₹ -53.06B	₹ -6.90B	₹ -79.44B	₹ -57.25B
Financing Cash Flow	₹ -21.81B	₹ -79.06B	₹ -67.10B	₹ 23.76B	₹ -51.93B

Currency in INR

Sun Pharmaceutical Industries Limited Earnings and Revenue History

Income Statement >

Sun Pharmaceutical Industries Limited Debt to Assets

Balance Sheet >

Sun Pharmaceutical Industries Limited Cash Flow

Cash Flow >

Sun Pharmaceutical Industries Limited Forecast EPS vs Actual EPS

Earnings >